首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >The effect of the ETA receptor antagonist FR 139317 on 125I-ET-1 binding to the atherosclerotic human coronary artery.
【2h】

The effect of the ETA receptor antagonist FR 139317 on 125I-ET-1 binding to the atherosclerotic human coronary artery.

机译:ETA受体拮抗剂FR 139317对125I -ET-1与动脉粥样硬化人冠状动脉结合的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The distribution of [125I]-endothelin (ET-1) binding sites on atherosclerotic human epicardial coronary arteries has been studied by in vitro receptor autoradiography. 2. [125I]-ET-1 binding was to the tunica media and regions of neovascularization. 3. Competition studies were carried out in the presence of ET-1 and the ETA receptor antagonist, FR 139317. The IC50 values for ET-1 at the tunica media and regions of neovascularization were similar (mean +/- s.e.mean of n = 4 patients, 2.5 +/- 0.9 nM and 2.9 +/- 0.9 nM, respectively) whereas IC50 values for FR 139317 at regions of neovascularization (607 +/- 34 nM) were significantly higher than those of the tunica media (12.6 +/- 2.4 nM) (P < 0.0001). 4. These results indicate that ETA receptors are present on the tunica media of the diseased human coronary artery whereas a different ET receptor subtype exists at regions of neovascularization.
机译:1.已通过体外受体放射自显影研究了[125I]-内皮素(ET-1)结合位点在动脉粥样硬化人心外膜冠状动脉上的分布。 2. [125I] -ET-1与中膜和新生血管形成区域结合。 3.在存在ET-1和ETA受体拮抗剂FR 139317的情况下进行了竞争研究。在中膜和新生血管形成区域,ET-1的IC50值相似(平均值+/- s n = 4例患者,分别为2.5 +/- 0.9 nM和2.9 +/- 0.9 nM),而新血管形成区域的FR 139317的IC50值(607 +/- 34 nM)显着高于中膜(12.6 + / -2.4 nM)(P <0.0001)。 4.这些结果表明,在患病的人冠状动脉的中膜介质上存在ETA受体,而在新血管形成区域存在不同的ET受体亚型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号